IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Euclidean Capital LLC

Q4 2024 Holdings

Filed 2025-02-14 | 11 holdings | $736.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$525.3M896,25471.3%
Ishares TR(INDA)MSCI INDIA ETF46429B598$127.7M2,425,14417.3%
Vanguard Intl Equity Index F(VEU)ALLWRLD EX US922042775$58.2M1,013,4347.9%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$8.0M989,4101.1%
Foghorn Therapeutics Inc(FHTX)COM344174107$7.4M1,573,7611.0%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$4.0M2,627,6430.5%
Alector Inc(ALEC)COM014442107$2.5M1,307,8580.3%
Tenaya Therapeutics Inc(TNYA)COM87990A106$1.5M1,015,7050.2%
Surrozen Inc(SRZN)COM NEW86889P208$1.3M87,6960.2%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$1.0M657,8990.1%
Surrozen Inc(SRZNW)*W EXP 08/01/20386889P117$3.7K170,8330.0%